Yes, both are used for blood sugar control and weight management, depending on medical approval and prescribing goals
This combination data is largely preclinical and short-term and has not been validated in large human trials
This makes sense on paper, but there are no large human studies proving the combo works better than using just one
Patients should continue their established IBS dietary strategies, such as the low-FODMAP diet if previously effective, while also adapting to the appetite-suppressing effects of these medications
In animal models of bone defects, GHK-Cu accelerated new bone formation and improved the mineral density of the regenerated tissue
In this scenario, the surviving tubular cells exhibit the peculiar phenotype associated with fibrosis that is the histological manifestation of a process culminating in chronic and end-stage kidney disease